Shares & Derivatives
Hyphens Pharma: Is this pharma company undervalued?
By New Academy of Finance  •  June 22, 2020
HYPHENS PHARMA: SINGAPORE’S LEADING SPECIALTY PHARMA AND CONSUMER HEALTHCARE GROUP Hyphens Pharma (Hyphens) is Singapore’s leading specialty pharmaceutical and consumer healthcare group. The company operates in three business segments:
  1. Specialty Pharma Principals which is the largest contributor of both revenue and earnings to the Group. The company boasts more than 30 products in its portfolio and this figure is consistently increasing.
  2. Proprietary Brands currently comprise of dermocosmetic products marketed under Ceradan® and TDF® brands as well as health supplement products marketed under their Ocean Health® brand. While this segment generates the lowest profitability among the three segments due to heavy investments in brand building, it has the highest revenue growth potential as well as earnings longevity.
  3. Medical Hypermart and Digital is a B2B model where the company engages in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan. This segment is the second-largest revenue and earnings contributor to the Group but we note the potential lumpiness in revenue/earnings from one-off large tenders.
...
Read the full article
By New Academy of Finance
I have got no sob-stories to entertain ya. I am just a regular joe, happily married, with two “highly energetic” young boys that can never seem to settle down! Life is peaceful, or if you wish to put it with a tad of negative connotation to it, BORING. Some say boring is good!
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance